Epigenetic regulation of tolerance to toll-like receptor ligands in alveolar epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 6, 2015, Pages 872-881

  Neagos, Jacqueline ^a   Standiford, Theodore J ^a   Newstead, Michael W ^a   Zeng, Xianying ^a   Huang, Steven K ^a   Ballinger, Megan N ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Alveolar epithelial cells; Endotoxin tolerance; Epigenetics; Toll like receptors

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; MICRORNA 146A; MICRORNA 155; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; VORINOSTAT; CHEMOKINE; LIGAND; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DNA METHYLATION; EPIGENETICS; HISTONE DEMETHYLATION; IMMUNOLOGICAL TOLERANCE; LUNG ALVEOLUS EPITHELIUM CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; CELLS, CULTURED; CHEMOKINES; EPIGENESIS, GENETIC; GENE EXPRESSION; IMMUNE TOLERANCE; LIGANDS; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTORS;

EID: 84963818095     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0057OC     Document Type: Article

References (52)

1. Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006;12:133-150.
2. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009;30: 475-487.
3. Curotto de Lafaille MA, Lafaille JJ, Graca L. Mechanisms of tolerance and allergic sensitization in the airways and the lungs. Curr Opin Immunol 2010;22:616-622.
4. Sanz Y, De Palma G. Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 2009;28:397-413.
5. Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in noninfectious lung injury. Cell Res 2006;16:693-701.
6. Hornef MW, Bogdan C. The role of epithelial Toll-like receptor expression in host defense and microbial tolerance. J Endotoxin Res 2005;11:124-128.
7. MacIa L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 2012;245:164-176.
8. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 2013;342:447-453.
9. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002;110:191-202.
10. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003;4: 920-927.
11. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, et al. Regulation of the germinal center response by microRNA-155. Science 2007;316: 604-608.
12. Corti M, Brody AR, Harrison JH. Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mole Biol 1996;14: 309-315.
13. Ballinger MN, Newstead MW, Zeng X, Bhan U, Horowitz JC, Moore BB, Pinsky DJ, Flavell RA, Standiford TJ. TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death. J Immunol 2012;189:356-364.
14. Tateda K, Deng JC, Moore TA, Newstead MW, Paine R III, Kobayashi N, Yamaguchi K, Standiford TJ. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: The role of apoptosis. J Immunol 2003;170:4209-4216.
15. Lyn-Kew K, Rich E, Zeng X, Wen H, Kunkel SL, Newstead MW, Bhan U, Standiford TJ. IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis. PLoS One 2010;5: E11145.
16. Sun J, Fegan PE, Desai AS, Madara JL, Hobert ME. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G767-G778.
17. Go H, Koh J, Kim HS, Jeon YK, Chung DH. Expression of Toll-like receptor 2 and 4 is increased in the respiratory epithelial cells of chronic idiopathic interstitial pneumonia patients. Respir Med 2014; 108:783-792.
18. Thorley AJ, Grandolfo D, Lim E, Goldstraw P, Young A, Tetley TD. Innate immune responses to bacterial ligands in the peripheral human lung-role of alveolar epithelial TLR expression and signalling. PLoS One 2011;6:e21827.
19. Raoust E, Balloy V, Garcia-Verdugo I, Touqui L, Ramphal R, Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One 2009;4:e7259.
20. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005;280:5571-5580.
21. Xiong Y, Medvedev AE. Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20. J Leukoc Biol 2011;90:1141-1148.
22. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007;26:461-475.
23. Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int 2006;26:935-942.
24. Piao W, Song C, Chen H, Diaz MA, Wahl LM, Fitzgerald KA, Li L, Medvedev AE. Endotoxin tolerance dysregulates MyD88- And Toll/IL-1R domain-containing adapter inducing IFNbeta- dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009;86: 863-875.
25. Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011;8:388-403.
26. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082-5089.
27. Nahid MA, Satoh M, Chan EK. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011;186:1723-1734.
28. Saturnino SF, Prado RO, Cunha-Melo JR, Andrade MV. Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcepsilonR1 interactions and SOCS expression: perspectives on immunomodulation in infectious and allergic diseases. BMC Infect Dis 2010;10:240.
29. Peng Q, O'Loughlin JL, Humphrey MB. DOK3 negatively regulates LPS responses and endotoxin tolerance. PLoS One 2012;7:e39967.
30. Chae BS. Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin. Arch Pharm Res 2002;25:910-916.
31. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447:972-978.
32. Moncayo-Nieto OL, Wilkinson TS, Brittan M, McHugh BJ, Jones RO, Conway Morris A, Walker WS, Davidson DJ, Simpson AJ. Differential response to bacteria, and TOLLIP expression, in the human respiratory tract. BMJ Open Respir Res 2014;1:e000046.
33. Kanaan Z, Barnett R, Gardner S, Keskey B, Druen D, Billeter A, Cheadle WG. Differential microRNA (miRNA) expression could explain microbial tolerance in a novel chronic peritonitis model. Innate Immun 2013;19:203-212.
34. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 2003;9:101-107.
35. West MA, Heagy W. Endotoxin tolerance: A review. Crit Care Med 2002; 30:S64-S73.
36. Draisma A, Pickkers P, Bouw MP, van der Hoeven JG. Development of endotoxin tolerance in humans in vivo. Crit Care Med 2009;37: 1261-1267.
37. de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van Veer C, van der Poll T. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009;183:533-542.
38. Kallapur SG, Jobe AH, Ball MK, Nitsos I, Moss TJ, Hillman NH, Newnham JP, Kramer BW. Pulmonary and systemic endotoxin tolerance in preterm fetal sheep exposed to chorioamnionitis. J Immunol 2007;179:8491-8499.
39. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006;203:973-984.
40. Savidge TC, Newman PG, Pan WH, Weng MQ, Shi HN, McCormick BA, Quaroni A, Walker WA. Lipopolysaccharide-induced human enterocyte tolerance to cytokine-mediated interleukin-8 production may occur independently of TLR-4/MD-2 signaling. Pediatr Res 2006;59:89-95.
41. Oshima N, Ishihara S, Rumi MA, Aziz MM, Mishima Y, Kadota C, Moriyama I, Ishimura N, Amano Y, Kinoshita Y. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010; 159:185-198.
42. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004;126:1054-1070.
43. Harada K, Sato Y, Isse K, Ikeda H, Nakanuma Y. Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia. Liver Int 2008;28:614-621.
44. Thet LA, Wrobel DJ, Crapo JD, Shelburne JD. Morphologic aspects of the protection by endotoxin against acute and chronic oxygeninduced lung injury in adult rats. Laboratory Invest 1983;48:448-457.
45. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004;31: 241-245.
46. Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmacol 2011;11:1399-1406.
47. Becker S, Mundandhara S, Devlin RB, Madden M. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol Appl Pharmacol 2005;207:269-275.
48. Ledford H. Language: disputed definitions. Nature 2008;455: 1023-1028.
49. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 2011;6:273-283.
50. Kiguchi N, Kobayashi Y, Saika F, Kishioka S. Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury. Cytokine 2013;64:666-672.
51. Baird AM, Gray SG, O'Byrne KJ. Epigenetics underpinning the regulation of the CXC (ELR1) chemokines in non-small cell lung cancer. PLoS One 2011;6:e14593.
52. Comer BS, Ba M, Singer CA, Gerthoffer WT. Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther 2015;147:91-110.